8-K Keros Therapeutics, Inc. 2026-09-08: filed_by
| Value | {"cik": "0001664710", "company": "Keros Therapeutics, Inc.", "accession": "0001664710-26-000053", "entity_ref": "e63e46fd-e44b-404e-9b31-a5d31709dd44", "period_of_report": "2026-09-08"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Keros Therapeutics, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1664710/000166471026000053/0001664710-26-000053-in
Retrieved: 2026-09-08T22:14:46.800340+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/589d7f9e-db94-4631-a9d9-170fcdfe00de
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1664710/000166471026000053/0001664710-26-000053-in
Retrieved: 2026-09-08T22:14:46.800340+02:00
Raw response sha256:
1ade6943d95f759ca8638c44b707b6a9…Cite as: FACTANKER, https://factanker.com/fact/589d7f9e-db94-4631-a9d9-170fcdfe00de
History
- no predecessors — first report